Liz KaneImpactful Strategy
Stacey GandlerBrand Nourishment
Paul TheisenPatient Acquisition
Amy GilesIncreasing Engagement
Bud BilanichSuccess Coach
Brenda SnowAuthentic Patient Voice
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Matt TurnerPatient Affordability
Matthew DurhamOmnidynamic Marketing
David LinetskyPoint-of-Care Marketing
Suma Ramadas, PhDMedical Affairs
Frank BurrellScientific Storytelling
Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in ...
First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email